Sg Americas Securities, LLC Amarin Corp Plcuk Transaction History

Sg Americas Securities, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$3.24 - $5.18 $84,751 - $135,498	-26,158 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$3.94 - $5.84 $35,357 - $52,408	8,974 Added 52.22%	26,158 $133,000
Q2 2021 Aug 12, 2021	BUY	$4.26 - $6.5 $14,897 - $22,730	3,497 Added 25.55%	17,184 $75,000
Q1 2021 May 13, 2021	SELL	$5.03 - $8.8 $25,114 - $43,938	-4,993 Reduced 26.73%	13,687 $85,000
Q4 2020 Feb 04, 2021	BUY	$4.04 - $5.31 $75,467 - $99,190	18,680 New	18,680 $91,000
Q2 2020 Jul 20, 2020	SELL	$4.78 - $8.26 $51,059 - $88,233	-10,682 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$4.0 - $21.53 $42,728 - $229,983	10,682 New	10,682 $43,000
Q2 2019 Jul 29, 2019	SELL	$16.27 - $20.51 $107,349 - $135,324	-6,598 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$12.61 - $22.33 $565,117 - $1 Million	-44,815 Reduced 87.17%	6,598 $137,000
Q4 2018 Feb 01, 2019	BUY	$12.41 - $22.98 $638,035 - $1.18 Million	51,413 New	51,413 $700,000
Q4 2017 Jan 24, 2018	SELL	$3.06 - $4.09 $33,204 - $44,380	-10,851 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$3.03 - $3.72 $32,878 - $40,365	10,851	10,851 $38,000

182

71.1M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $218M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.